Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Independence BCBS adds coverage for Senseonics' Eversense » 13:46
07/29/20
07/29
13:46
07/29/20
13:46
SENS

Senseonics

$0.51 /

+0.0332 (+6.98%)

In a policy bulletin…

In a policy bulletin dated July 28, Independence Blue Cross Blue Shield noted that its policy was updated to expand coverage for long-term interstitial continuous glucose monitoring systems for individuals with type 2 diabetes mellitus on an intensive insulin regimen defined as requiring three or more insulin injections per day, or utilizes an insulin pump. In addition, coverage was added for the implantation of an FDA-approved implantable glucose CGM system, for example Senseonics' Eversense, "when criteria for long-term interstitial CGMS is met," the policy bulletin states. Reference Link

ShowHide Related Items >><<
SENS Senseonics
$0.51 /

+0.0332 (+6.98%)

SENS Senseonics
$0.51 /

+0.0332 (+6.98%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
SENS Senseonics
$0.51 /

+0.0332 (+6.98%)

SENS Senseonics
$0.51 /

+0.0332 (+6.98%)

Over a month ago
On The Fly
Fly Intel: After-Hours Movers » 18:47
06/09/20
06/09
18:47
06/09/20
18:47
LAKE

Lakeland Industries

/

+

, FIVE

Five Below

/

+

, ITI

Iteris

/

+

, AMC

AMC Entertainment

/

+

, BCRX

BioCryst

/

+

, NATI

National Instruments

/

+

, NOMD

Nomad Foods

/

+

, SENS

Senseonics

/

+

, VRNT

Verint

/

+

, LMNR

Limoneira

/

+

, GME

GameStop

/

+

, BBCP

Concrete Pumping

/

+

, CHWY

Chewy

/

+

, DNLI

Denali Therapeutics

/

+

, NIO

NIO Inc.

/

+

, MNRL

Brigham Minerals

/

+

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
VRNT Verint
/

+

SENS Senseonics
/

+

NOMD Nomad Foods
/

+

NIO NIO Inc.
/

+

NATI National Instruments
/

+

MNRL Brigham Minerals
/

+

LMNR Limoneira
/

+

LAKE Lakeland Industries
/

+

ITI Iteris
/

+

GME GameStop
/

+

FIVE Five Below
/

+

DNLI Denali Therapeutics
/

+

CHWY Chewy
/

+

BCRX BioCryst
/

+

BBCP Concrete Pumping
/

+

AMC AMC Entertainment
/

+

LAKE Lakeland Industries
/

+

06/09/20 Benchmark
Benchmark starts PPE maker Lakeland Industries at Buy
06/09/20 Benchmark
Lakeland Industries initiated with a Buy at Benchmark
04/15/20 Roth Capital
Lakeland Industries resumed with a Buy at Roth Capital
03/19/20 Craig-Hallum
Lakeland Industries price target raised to $22 from $16 at Craig-Hallum
FIVE Five Below
/

+

06/08/20 Craig-Hallum
Five Below price target raised to $132 from $105 at Craig-Hallum
05/26/20 Deutsche Bank
Five Below price target raised to $102 from $99 at Deutsche Bank
05/18/20
Fly Intel: Top five analyst initiations
05/18/20 Goldman Sachs
Five Below initiated with a Neutral at Goldman Sachs
ITI Iteris
/

+

08/27/19
Iteris assumed with a Buy at Dougherty
AMC AMC Entertainment
/

+

06/05/20 Imperial Capital
AMC Entertainment price target raised to $4 from $3 at Imperial Capital
06/03/20 Barrington
Operating environment creates going concern uncertainty for AMC, says Barrington
05/27/20
Fly Intel: Top five analyst upgrades
05/27/20 MKM Partners
AMC Entertainment upgraded to Neutral from Sell at MKM Partners
BCRX BioCryst
/

+

05/06/20 JMP Securities
BioCryst has potential best-in-class PNH treatment, says JMP Securities
05/06/20 Piper Sandler
BioCryst price target raised to $10 from $8 at Piper Sandler
05/05/20 Barclays
BioCryst upgraded to Overweight from Equal Weight at Barclays
04/29/20 JMP Securities
Positive remdesivir news 'bodes well' for BioCryst, says JMP Securities
NATI National Instruments
/

+

04/14/20 JPMorgan
National Instruments initiated with a Neutral at JPMorgan
03/03/20 RBC Capital
National Instruments initiated with a Sector Perform at RBC Capital
01/09/20 Baird
National Instruments upgraded to Outperform at Baird
01/09/20 Baird
National Instruments upgraded to Outperform from Neutral at Baird
NOMD Nomad Foods
/

+

01/22/20 Jefferies
Nomad Foods initiated with a Buy at Jefferies
01/22/20 Jefferies
Nomad Foods initiated with a Buy at Jefferies
12/16/19 DA Davidson
Nomad Foods more investable after Conservative victory in UK, says DA Davidson
12/11/19 Deutsche Bank
Nomad Foods resumed with a Buy at Deutsche Bank
SENS Senseonics
/

+

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
VRNT Verint
/

+

04/03/20 Imperial Capital
Verint price target lowered to $54 from $69 at Imperial Capital
04/01/20 Needham
Verint price target lowered to $53 from $67 at Needham
04/01/20 Oppenheimer
Verint price target lowered to $64 from $70 at Oppenheimer
04/01/20 Wedbush
Verint price target lowered to $55 from $70 at Wedbush
LMNR Limoneira
/

+

04/27/20 National Securities
Limoneira upgraded to Buy from Neutral at National Securities
03/12/20 Roth Capital
Limoneira price target lowered to $17 from $22 at Roth Capital
03/12/20 Lake Street
Limoneira price target lowered to $18 from $23 at Lake Street
03/12/20 National Securities
Limoneira downgraded to Neutral from Buy at National Securities
GME GameStop
/

+

04/21/20 Baird
GameStop FY20 EPS target cut at Baird
03/27/20 Baird
GameStop trneds to remain weak despite recent increase, says Baird
03/20/20
Fly Intel: Top five analyst downgrades
03/20/20 Benchmark
GameStop does not qualify as an essential retailer, says Benchmark
BBCP Concrete Pumping
/

+

04/03/20 B. Riley FBR
Concrete Pumping downgraded on weakening markets at B. Riley FBR
04/03/20 B. Riley FBR
Concrete Pumping downgraded to Neutral from Buy at B. Riley FBR
03/24/20 Baird
Concrete Pumping downgraded to Neutral from at Baird
03/24/20 Baird
Concrete Pumping downgraded to Neutral from Outperform at Baird
CHWY Chewy
/

+

06/05/20 Cleveland Research
Chewy Q1 sales beat channel expectations, says Cleveland Research
06/05/20 Barclays
Chewy price target raised to $48 from $34 at Barclays
06/04/20 Wedbush
Chewy price target raised to $53 from $44 at Wedbush
04/20/20
Chewy cut to Neutral at UBS on longer term headwinds
DNLI Denali Therapeutics
/

+

03/13/20 Evercore ISI
Denali Therapeutics upgraded to Outperform from In Line at Evercore ISI
02/28/20 Wedbush
Denali Therapeutics pullback providing more attractive entry point, says Wedbush
02/28/20 Wedbush
Denali Therapeutics upgraded to Outperform from Neutral at Wedbush
02/24/20
Fly Intel: Top five analyst initiations
NIO NIO Inc.
/

+

06/09/20 86 Research
NIO Inc. initiated with a Sell at 86 Research
06/02/20 Goldman Sachs
NIO Inc. upgraded to Buy from Neutral at Goldman Sachs
05/27/20 JPMorgan
NIO Inc. upgraded to Neutral from Underweight at JPMorgan
MNRL Brigham Minerals
/

+

05/21/20 Capital One
Brigham Minerals downgraded to Equalweight from Overweight at Capital One
05/14/20 Credit Suisse
Brigham Minerals downgraded to Neutral following outperformance at Credit Suisse
05/14/20 Credit Suisse
Brigham Minerals downgraded to Neutral from Outperform at Credit Suisse
03/19/20 Credit Suisse
Brigham Minerals assumed with an Outperform at Credit Suisse
VRNT Verint
/

+

SENS Senseonics
/

+

NOMD Nomad Foods
/

+

NIO NIO Inc.
/

+

NATI National Instruments
/

+

MNRL Brigham Minerals
/

+

LMNR Limoneira
/

+

LAKE Lakeland Industries
/

+

ITI Iteris
/

+

GME GameStop
/

+

FIVE Five Below
/

+

DNLI Denali Therapeutics
/

+

CHWY Chewy
/

+

BCRX BioCryst
/

+

BBCP Concrete Pumping
/

+

AMC AMC Entertainment
/

+

  • 11
    Jun
  • 10
    Jun
NIO NIO Inc.
/

+

LAKE Lakeland Industries
/

+

GME GameStop
/

+

CHWY Chewy
/

+

AMC AMC Entertainment
/

+

VRNT Verint
/

+

NIO NIO Inc.
/

+

MNRL Brigham Minerals
/

+

LAKE Lakeland Industries
/

+

GME GameStop
/

+

FIVE Five Below
/

+

CHWY Chewy
/

+

BCRX BioCryst
/

+

AMC AMC Entertainment
/

+

NIO NIO Inc.
/

+

LAKE Lakeland Industries
/

+

GME GameStop
/

+

FIVE Five Below
/

+

CHWY Chewy
/

+

BCRX BioCryst
/

+

AMC AMC Entertainment
/

+

Earnings
Senseonics reports Q1 EPS (21c), consensus (13c) » 16:10
06/09/20
06/09
16:10
06/09/20
16:10
SENS

Senseonics

$0.51 /

+0.0151 (+3.04%)

As of March 31, 2020,…

As of March 31, 2020, cash, cash equivalents and restricted cash were $18.8 million and outstanding indebtedness was $98.7 million. CEO Tim Goodnow says: "In the second half of March we began to experience significant dislocation in the market because of the isolation efforts to prevent the transmission of COVID-19. As part of the public health considerations in response to the pandemic, most endocrinology clinics transitioned to telehealth interactions with patients, greatly limiting in-person visits and significantly reducing health care providers' ability to insert sensors for patients. These challenging market circumstances in combination with our financial situation led the Board to the decision to explore strategic alternatives for the company. Concurrent with this process we took steps to reorganize and reprioritize our corporate initiatives. To operate in the most efficient manner moving forward we have temporarily suspended commercial activities in the U.S. for new patients and have shifted our focus to long-term value creation through product development and market access. We remain committed to supporting our current patient base and ensuring the success of Eversense in the marketplace."

ShowHide Related Items >><<
SENS Senseonics
$0.51 /

+0.0151 (+3.04%)

SENS Senseonics
$0.51 /

+0.0151 (+3.04%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
SENS Senseonics
$0.51 /

+0.0151 (+3.04%)

Over a quarter ago
Hot Stocks
Senseonics announces 3 additional Blue Cross Blue Shield plans cover Eversense » 16:50
05/06/20
05/06
16:50
05/06/20
16:50
SENS

Senseonics

$0.53 /

-0.0016 (-0.30%)

Senseonics announced that…

Senseonics announced that three more Blue Cross Blue Shield plans are now providing coverage for the Eversense CGM System, effective immediately. These recent coverage decisions add to the growing number of payers who are writing Eversense into their CGM coverage policies, as well as paying for the healthcare provider's time for the in-office sensor placement. Blue Cross and Blue Shield of Arizona has added coverage for Eversense which expands access to approximately 1.5 million Arizona residents. CareFirst Blue Cross and Blue Shield offers health plans and administrative services to approximately 3.3 million individuals and employers in Maryland, the District of Columbia, and Northern Virginia and has expanded coverage for Eversense. Independence Blue Cross and AmeriHealth have also opened the door to coverage for Eversense as they serve approximately 4.8 million people in Pennsylvania and surrounding markets.

ShowHide Related Items >><<
SENS Senseonics
$0.53 /

-0.0016 (-0.30%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Syndicate
Senseonics files to sell 53.33M shares of common stock for holders  17:01
04/30/20
04/30
17:01
04/30/20
17:01
SENS

Senseonics

$0.57 /

-0.0264 (-4.41%)

 
ShowHide Related Items >><<
SENS Senseonics
$0.57 /

-0.0264 (-4.41%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Hot Stocks
Senseonics Eversense sensor gets MRI conditional approval in Europe » 16:20
04/28/20
04/28
16:20
04/28/20
16:20
SENS

Senseonics

$0.60 /

-0.0229 (-3.70%)

Senseonics announced…

Senseonics announced regulatory approval that the Eversense XL Sensor is no longer contraindicated for MRI which means that the sensor does NOT need to be removed from under the skin during MRI scanning. During scanning the external Eversense Smart Transmitter must still be removed, and once scanning is completed, the transmitter is easily repositioned on the skin.

ShowHide Related Items >><<
SENS Senseonics
$0.60 /

-0.0229 (-3.70%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Hot Stocks
Senseonics withdraws and suspends previously provided financial guidance » 08:21
03/27/20
03/27
08:21
03/27/20
08:21
SENS

Senseonics

$0.70 /

-0.0848 (-10.87%)

Senseonics said in a…

Senseonics said in a regulatory filing that due to the COVID-19 pandemic, the company is withdrawing and suspending its financial guidance that it previously provided for the year ending December 31, 2020. The company expects to provide a business update on its first quarter earnings call.

ShowHide Related Items >><<
SENS Senseonics
$0.70 /

-0.0848 (-10.87%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Hot Stocks
Senseonics suspends U.S. sales of 90-day Eversense system to new patients » 08:20
03/27/20
03/27
08:20
03/27/20
08:20
SENS

Senseonics

$0.70 /

-0.0848 (-10.87%)

In a regulatory filing,…

In a regulatory filing, Senseonics said that as art of the previously announced strategic review that it is conducting in connection with its evaluation of strategic alternatives, and considering the impact of the COVID-19 global pandemic on access to physician offices and medical facilities, the company is, effective immediately, suspending commercial sales in the United States of its 90-day Eversense continuous glucose monitoring system to new patients and physician practices. The company intends to continue distributing the 90-day Eversense system to patients who are currently using the product for the foreseeable future. The company also intends to continue supporting existing patients and their physicians. The company is evaluating its Eversense Bridge program and may revise, suspend or cancel this program in its entirety. The Company plans to continue its development and regulatory submission efforts for its Eversense XL CGM system for use for up to 180 days in the United States as disclosed in the company's Annual Report on Form 10-K for the year ended December 31, 2019. The company expects that cash used in operating activities for the quarter ending March 31, 2020 will be consistent with average quarterly operating cash outflows during 2019. However, the company expects that the cost reduction measures previously announced, including the suspension of commercial sales of the 90-day Eversense system, will significantly reduce the cash used in operations in future quarters. As previously announced, the Company is exploring strategic alternatives to enhance stakeholder value. The company is in discussions with new financing sources, which could include issuing additional equity or either secured or unsecured indebtedness or a combination of both.

ShowHide Related Items >><<
SENS Senseonics
$0.70 /

-0.0848 (-10.87%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Hot Stocks
Senseonics exploring strategic options » 08:33
03/23/20
03/23
08:33
03/23/20
08:33
SENS

Senseonics

$0.64 /

+0.0145 (+2.33%)

Senseonics Holdings…

Senseonics Holdings announced that its board has decided to explore potential strategic alternatives to enhance stakeholder value. The company is engaging Moelis & Company, LLC as its financial advisor and Cooley, LLP as its legal advisor. On March 22, the company terminated its Loan and Security Agreement with Solar Capital Ltd. and paid all amounts outstanding. Including a payoff fee and prepayment premium, the amount paid by the company totaled $48.5 million. Following the payoff of these obligations, the company has no secured debt outstanding. In light of this repayment, the company is in discussions with new financing sources. The intention is to provide sufficient funding flexibility to enable the Board to complete its strategic review and provide stability to the company in light of the ongoing market dislocation caused by the COVID-19 pandemic. As part of its strategic review, the company has determined to focus its operations on the core activities required to ensure the long-term success of the Eversense CGM System. The company believes that this will allow reductions in its cost structure and improvements in its operating cash flow, in addition to generating future capital expenditure savings. The strategic alternatives could include a sale of the company. There can be no assurance that the company will pursue any particular action or transaction; however, Senseonics will assess all viable paths to enhancing stakeholder value. The company does not intend to provide updates regarding its strategic review unless or until it determines that further disclosure is necessary.

ShowHide Related Items >><<
SENS Senseonics
$0.64 /

+0.0145 (+2.33%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord
Hot Stocks
Senseonics exploring strategic options  08:32
03/23/20
03/23
08:32
03/23/20
08:32
SENS

Senseonics

$0.64 /

+0.0145 (+2.33%)

 
ShowHide Related Items >><<
SENS Senseonics
$0.64 /

+0.0145 (+2.33%)

03/13/20 Guggenheim
Senseonics downgraded to Neutral on lack of commercial progress at Guggenheim
03/13/20 BTIG
Senseonics downgraded to Neutral from Buy at BTIG
03/13/20 Guggenheim
Senseonics downgraded to Neutral from Buy at Guggenheim
11/13/19 Canaccord
Senseonics downgraded to Hold at Canaccord

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.